People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Interline Therapeutics, Inc. | — | Pharma | Series C | $92.6M | $1.1B | 2021 |
| Affini-T Therapeutics, Inc. | — | Biotechnology | Series B | $17.6M | $121.2M | 2024 |
Michael Varney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Varney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lucio Iannone | 1 | 6 |
| James Tananbaum | 1 | 6 |
| Arjun Goyal | 1 | 5 |
| Vikram Bajaj | 1 | 3 |
| Kathy Yi | 1 | 2 |
| Jay Parrish | 1 | 2 |
| Joseph Knowles | 1 | 1 |
| Zachary Sweeney | 1 | 1 |
| Kathy Bergsteinsson | 1 | 1 |
| Vikam Bajaj | 1 | 1 |
| Jill DeSimone | 1 | 1 |
| Daniel Faga | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.